✦ LIBER ✦

Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer: North Japan Lung Cancer Group Trial 0802

✍ Scribed by Kawashima, Yosuke; Inoue, Akira; Sugawara, Shunichi; Oizumi, Satoshi; Maemondo, Makoto; Okudera, Koichi; Suzuki, Toshiro; Usui, Kazuhiro; Harada, Masao; Morikawa, Naoto; Hasegawa, Yukihiro; Saito, Ryota; Ishimoto, Osamu; Sakakibara, Tomohiro; Asahina, Hajime; Nukiwa, Toshihiro

Book ID: 122322515
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 353 KB
Volume: 52
Category: Article
ISSN: 2212-5345
DOI: 10.1016/j.resinv.2013.12.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of amrubicin and carbopla

Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer

✍ Hirose, Takashi; Nakashima, Masanao; Shirai, Takao; Kusumoto, Sojiro; Sugiyama, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Phase II study of weekly irinotecan and

Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer

✍ Naka, Nobuyuki; Kawahara, Masaaki; Okishio, Kyoichi; Hosoe, Shigeto; Ogawara, Mi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 84 KB

A phase II study of amrubicin and topote

A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401

✍ Nogami, Naoyuki; Hotta, Katsuyuki; Kuyama, Shoichi; Kiura, Katsuyuki; Takigawa, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Phase I and pharmacologic study of weekl

Phase I and pharmacologic study of weekly amrubicin in patients with refractory or relapsed lung cancer: Central Japan Lung Study Group (CJLSG) 0601 trial

✍ Chiyoe Kitagawa; Hideo Saka; Shigehisa Kajikawa; Kouki Mori; Masahide Oki; Ryuji 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 301 KB

Pilot phase II study of weekly chemother

Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 192 KB

Phase II study of irinotecan and carbopl

Phase II study of irinotecan and carboplatin in patients with the refractory or relapsed small cell lung cancer

✍ Hirose, Takashi; Horichi, Naoya; Ohmori, Tohru; Ogura, Keiichi; Hosaka, Takamich 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB